準備中
PI for a clinical trial sponsored by the Alzheimer’s Association, and is a site clinician for clinical trials sponsored by Eisai, the Alzheimer's Treatment and Research Institute at USC, and Transposon Therapeutics, Inc.
Importantly, drugs like lecanemab and donanemab are not cures for AD and there is no evidence to suggest that these agents halt or reverse cognitive impairment.
併用か
5
586
